Volume 30, Number 6—June 2024
Synopsis
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France
Table 3
Variables | SOS, n = 7 | Literature, n = 13 | Total, n = 20 |
---|---|---|---|
Radical surgery |
2/7 (29) |
6/13 (46) |
8/20 (40) |
First-line antifungal treatment after microbiologic identification | |||
Monotherapy | 1/7 (14) | 3/9 (33) | 4/16 (25) |
Combination therapy | 5/7 (71) | 5/9 (56) | 10/16 (63) |
Multitherapy, >3 antifungal agents | 1/7 (14) | 1/9 (11) | 2/16 (13) |
Voriconazole | 7/7 (100) | 9/9 (100) | 16/16 (100) |
Terbinafine | 2/7 (29) | 6/9 (67) | 8/16 (50) |
Caspofungin |
5/7 (71) |
1/9 (11) |
6/16 (38) |
Overall IFD-related deaths | 5/7 (71) | 7/11 (64) | 12/18 (67) |
Among patients with fungemia | 4/4 (100) | 3/3 (100) | 7/7 (100) |
Among patients with aortitis whether or not associated with arteritis | 4/5 (80) | 7/9 (78) | 11/14 (79) |
Among patients with arteritis only | 1/2 (50) | 0/2 (0) | 1/4 (25) |
Among patients treated with radical surgery and antifungal | 1/2 (50) | 1/4 (25) | 2/6 (33) |
Among patients treated with antifungal only |
4/5 (80) |
3/4 (75) |
7/9 (78) |
1-month IFD-related deaths | 2/7 (29) | 5/11 (46) | 7/18 (39) |
*Values are no./total no. analyzed (%). Denominators are different in some cases because of missing data. Patients had non–central nervous system vascular infections caused by Scedosporium spp. or Lomentospora prolificans; cases were obtained from the SOS and published literature. IFD, invasive fungal disease; SOS, Scedosporiosis/lomentosporiosis Observational Study.
Page created: March 28, 2024
Page updated: May 22, 2024
Page reviewed: May 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.